Yang-Monti回肠代输尿管术的长期疗效:适用于轻中度肾功能损失及孤立肾
本研究回顾性分析2001年至2019年间36例接受Yang-Monti回肠代输尿管术的患者,中位年龄46.5岁,其中6例为孤立肾。中位随访68个月,结果显示整体及慢性肾病(2、3a、3b期)和孤立肾患者的血清肌酐、分肾清除率及eGFR均显著改善,并发症少,无代谢并发症。结论认为该术式持久有效,可用于轻中度肾功能损失和孤立肾,eGFR<40 mL/min/1.73 m²为相对禁忌。
要点
- Yang-Monti回肠代输尿管术可显著改善整体、慢性肾病及孤立肾患者的肾功能参数。
- 术后并发症少,无代谢并发症,但10例发生尿路感染。
- eGFR<40 mL/min/1.73 m²视为相对禁忌证。
核心结论
- Yang-Monti回肠代输尿管术持久有效,能改善肾功能且并发症少。
- 该术式可安全用于轻中度肾功能损失和孤立肾患者。
- eGFR<40 mL/min/1.73 m²被视为相对禁忌证。
研究设计与样本
- 回顾性分析2001年3月至2019年12月间36例接受Yang-Monti回肠代输尿管术的患者。
- 患者中位年龄46.5岁,其中6例为孤立肾。
- 慢性肾病分期:1期4例,2期14例,3a期15例,4a期3例。
主要发现
- 输尿管狭窄病因包括医源性(16例)、血吸虫性(7例)、结核性(4例)、腹膜后纤维化(5例)、恶性肿瘤(3例)和枪伤(1例)。
- 中位输尿管缺损长度为11 cm(范围8-16 cm)。
- 术后Clavien-Dindo 1/2级并发症4例,肠梗阻1例,尿路感染10例。
- 中位随访68个月(范围12-215个月),末次随访时整体、慢性肾病(2、3a、3b期)及孤立肾患者的血清肌酐、分肾清除率和eGFR较术前显著改善。
- 4例慢性肾病3期患者肾功能参数恶化,磁共振尿路成像显示多数患者肾积水改善,无代谢并发症。
关键数值与推荐
- eGFR<40 mL/min/1.73 m²视为相对禁忌证。
临床怎么用
- 对于轻中度肾功能损失或孤立肾的输尿管缺损患者,可考虑Yang-Monti回肠代输尿管术。
- 术前应评估eGFR,若eGFR<40 mL/min/1.73 m²则视为相对禁忌。
- 术后需定期随访肾功能、形态学及并发症,注意尿路感染和肠梗阻风险。
局限性
- 本研究为回顾性单中心研究,样本量较小(36例)。
- 缺乏对照组,随访时间范围较大(12-215个月)。
- 部分慢性肾病3期患者肾功能恶化,需进一步评估影响因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To present long-term outcome of Yang-Monti ileal ureter, with a focus on patients with mild/moderate loss of kidney function and solitary kidney. PATIENTS AND METHODS: Between March 2001 and December 2019, Yang-Monti ileal ureter was performed on 36 patients with ureteric defects and median age 46.5 years. Of these, 4, 14, 15 and 3 patients had stage 1, stage 2, stage 3a and stage 4a chronic kidney disease, respectively; 6 had solitary kidney. Patients were regularly followed for complications, morphological, and functional outcome. RESULTS: Ureteric stricture etiology was iatrogenic (16), Bilharzial (7), tuberculous (4), retroperitoneal fibrosis (5), malignancy (3), and gunshot injury (1). The median (range) ureteric defect length was 11 (8-16) cm. Four grade 1/2 postoperative Clavien-Dindo complications were noted. Median follow-up was 68 months (range 12-215). Intestinal obstruction developed in 1 patient and urinary tract infection in 10. At last follow-up, serum creatinine, split renographic clearance, and estimated glomerular filtration rate showed significant improvement compared to preoperative values, in the whole series, in cases with chronic kidney disease (stages 2, 3a and 3b) and solitary kidney. Four cases with chronic kidney disease (stage 3) showed deterioration of the kidney function parameters. Magnetic resonance urography showed improvement of hydronephrosis in most patients. No metabolic complications were noted. CONCLUSION: Yang-Monti Ileal ureter is durable and effective in improving kidney function with few complications. It can be safely used in cases of mild/moderate kidney function loss and solitary kidney. A threshold eGFR <40 mL/min/1.73 m2 is considered relative contraindication.
引用
- Ali-El-Dein B, El-Hefnawy AS, D' Elia G, et al. Long-term Outcome of Yang-Monti Ileal Replacement of the Ureter: A Technique Suitable for Mild, Moderate Loss of Kidney Function and Solitary Kidney. Urology. 2021. PMID: 33359492. doi:10.1016/j.urology.2020.09.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。